Literature DB >> 2207221

Eating disorders and depression: is there a serotonin connection?

D C Jimerson1, M D Lesem, W H Kaye, A P Hegg, T D Brewerton.   

Abstract

Central serotonin pathways modulate eating patterns, and may also participate in the regulation of behavioral impulsivity and mood. Recent studies lend support to the hypothesis that impaired postingestive satiety in bulimia nervosa is associated with reduced hypothalamic serotonergic responsiveness. Serotonin dysregulation has been implicated in major depression, and may play a role in the increased prevalence of depressive episodes in patients with eating disorders. This review compares evidence for alterations in central serotonin regulation in patients with anorexia nervosa, bulimia nervosa, and depression. It is proposed that impaired synaptic transmission in functionally distinct serotonin pathways may result in concurrent or sequential periods of binge eating, behavioral impulsivity, and depression in patients with eating disorders.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2207221     DOI: 10.1016/0006-3223(90)90412-u

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  17 in total

1.  Estrogens stimulate serotonin neurons to inhibit binge-like eating in mice.

Authors:  Xuehong Cao; Pingwen Xu; Mario G Oyola; Yan Xia; Xiaofeng Yan; Kenji Saito; Fang Zou; Chunmei Wang; Yongjie Yang; Antentor Hinton; Chunling Yan; Hongfang Ding; Liangru Zhu; Likai Yu; Bin Yang; Yuxin Feng; Deborah J Clegg; Sohaib Khan; Richard DiMarchi; Shaila K Mani; Qingchun Tong; Yong Xu
Journal:  J Clin Invest       Date:  2014-08-26       Impact factor: 14.808

Review 2.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

Review 3.  Is anorexia nervosa a neuropsychological disease?

Authors:  C M Braun; M J Chouinard
Journal:  Neuropsychol Rev       Date:  1992-06       Impact factor: 7.444

Review 4.  Neurobiology of aversive states.

Authors:  Erin N Umberg; Emmanuel N Pothos
Journal:  Physiol Behav       Date:  2011-05-01

Review 5.  Nutritional interventions for individuals with bulimia nervosa.

Authors:  S J Salvy; L McCargar
Journal:  Eat Weight Disord       Date:  2002-12       Impact factor: 4.652

6.  Citalopram in anorexia nervosa.

Authors:  S Pallanti; L Quercioli; A Ramacciotti
Journal:  Eat Weight Disord       Date:  1997-12       Impact factor: 4.652

7.  A history of caloric restriction induces neurochemical and behavioral changes in rats consistent with models of depression.

Authors:  P C Chandler-Laney; E Castaneda; C E Pritchett; M L Smith; M Giddings; A I Artiga; M M Boggiano
Journal:  Pharmacol Biochem Behav       Date:  2007-04-11       Impact factor: 3.533

Review 8.  Psychotropic drugs in the treatment of obesity: what promise?

Authors:  Jose C Appolinario; João R Bueno; Walmir Coutinho
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Membrane glycoprotein M6B interacts with the human serotonin transporter.

Authors:  Anja Winther Fjorback; Heidi Kaastrup Müller; Ove Wiborg
Journal:  J Mol Neurosci       Date:  2008-06-26       Impact factor: 3.444

10.  Correlations of plasma and urinary phenylacetic acid and phenylethylamine concentrations with eating behavior and mood rating scores in brofaromine-treated women with bulimia nervosa.

Authors:  B A Davis; S H Kennedy; J D'Souza; D A Durden; D S Goldbloom; A A Boulton
Journal:  J Psychiatry Neurosci       Date:  1994-07       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.